Approval · Notice of Compliance 22424 · 2019
TOBI: Notice of Compliance 22424
Issued July 19, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22424
- Date
- July 19, 2019
- Company
- BGP Pharma ULCEtobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Change in Product Ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TOBI | 02239630 | Marketed |
Medicinal ingredients
- TOBRAMYCIN SULFATE 300 MG per 5ML